Global CRISPR & Cas9 Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global CRISPR & Cas9 market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
The Global Info Research report includes an overview of the development of the CRISPR & Cas9 industry chain, the market status of Biotechnology Companies (Genome Editing, Genetic Engineering), Pharmaceutical Companies (Genome Editing, Genetic Engineering), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CRISPR & Cas9.
Regionally, the report analyzes the CRISPR & Cas9 markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CRISPR & Cas9 market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CRISPR & Cas9 market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CRISPR & Cas9 industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Genome Editing, Genetic Engineering).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CRISPR & Cas9 market.
Regional Analysis: The report involves examining the CRISPR & Cas9 market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CRISPR & Cas9 market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CRISPR & Cas9:
Company Analysis: Report covers individual CRISPR & Cas9 players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CRISPR & Cas9 This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biotechnology Companies, Pharmaceutical Companies).
Technology Analysis: Report covers specific technologies relevant to CRISPR & Cas9. It assesses the current state, advancements, and potential future developments in CRISPR & Cas9 areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CRISPR & Cas9 market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CRISPR & Cas9 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Market segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Market segment by players, this report covers
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRISPR & Cas9 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRISPR & Cas9, with revenue, gross margin and global market share of CRISPR & Cas9 from 2019 to 2024.
Chapter 3, the CRISPR & Cas9 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CRISPR & Cas9 market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRISPR & Cas9.
Chapter 13, to describe CRISPR & Cas9 research findings and conclusion.